PUBLISHER: Polaris Market Research | PRODUCT CODE: 1526394
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1526394
The global digital PCR market size is expected to reach USD 18.78 billion by 2032, according to a new study by Polaris Market Research. The report "Global Digital PCR Market Size, Share, Trends, Industry Analysis Report: By Product Offering (Reagent & Consumables, Instruments, Software, Services), By Technology, By Application, By End User, and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Digital PCR offers unparalleled precision and sensitivity in detecting and quantifying nucleic acids. Unlike traditional PCR, which provides semi-quantitative results, dPCR allows for absolute quantification. It is highly valuable in clinical diagnostics, especially for detecting low-abundance targets such as circulating tumor DNA (ctDNA) and rare genetic mutations. This accuracy is crucial for early disease detection, personalized medicine, and monitoring treatment responses, driving its adoption in the medical field.
The increasing incidence of chronic diseases, such as cancer, infectious diseases, and genetic disorders, has escalated the need for advanced diagnostic tools. dPCR's ability to provide precise measurements of genetic material plays a vital role in early diagnosis and management of these conditions, thereby boosting its demand. The technology is particularly important in oncology for detecting minimal residual disease and monitoring disease progression.
Continuous innovations in dPCR technology, such as the development of multiplexing capabilities, automation, and integration with data analysis tools, enhance its efficiency and ease of use. These advancements make dPCR more accessible and attractive to a broader range of users, including research institutions, clinical laboratories, and biopharmaceutical companies.
Significant investment in research and development by key market players is leading to the introduction of advanced dPCR systems and applications. Continuous innovation and improvement in dPCR technology are essential for meeting the evolving needs of end-users and maintaining dPCR market growth.
In summary, the demand for the digital PCR market is fueled by its precision, sensitivity, and expanding applications across various fields. The technology's ability to provide accurate and reliable nucleic acid quantification is crucial for advancing diagnostics, research, agriculture, and environmental testing, driving its widespread adoption and digital PCR market growth.
The instruments segment accounted for the largest market share in 2023 due to continuous innovations in dPCR instruments have led to the development of highly sophisticated and efficient systems.
The research application segment under the QPCR application held the largest market share in 2023 due to its extensive use in various research fields, including genomics, molecular biology, and biotechnology.
In 2023, North America held the largest share of the global market due to its highly developed healthcare infrastructure. The availability of cutting-edge laboratory facilities and advanced diagnostic equipment has facilitated the widespread adoption of dPCR technology.
The Asia-Pacific digital PCR Market is expected to grow at the highest CAGR during the forecast period due to a surge in research and development activities across various fields, including genomics, biotechnology, and pharmaceuticals.
The global key market players include Thermo Fisher Scientific Inc., QIAGEN, Bio-Rad Laboratories, Inc., Sysmex Corporation, JN Medsys, Stilla, Standard BioTools Inc., Precigenome LLC., F. Hoffmann-La Roche Ltd., and Avance Biosciences, and more.
Polaris Market Research has segmented the digital PCR market report based on product offering, technology, application, end-user, and region:
List of Tables:
List of Figures: